Soligenix
SNGX
#11002
Rank
ยฃ5.45 M
Marketcap
ยฃ0.25
Share price
0.51%
Change (1 day)
-75.77%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2023 (TTM): -ยฃ2.27

According to Soligenix's latest financial reports the company's current EPS (TTM) is -ยฃ1.35. In 2022 the company made an earnings per share (EPS) of -ยฃ3.31 a decrease over its 2021 EPS that were of -ยฃ3.16.

EPS history for Soligenix from 1998 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ2.27-31.47%
2022-ยฃ3.314.93%
2021-ยฃ3.16-58%
2020-ยฃ7.5236.73%
2019-ยฃ5.50-33.78%
2018-ยฃ8.30-36.75%
2017-ยฃ13.1227.17%
2016-ยฃ10.32-70.23%
2015-ยฃ34.66-3.44%
2014-ยฃ35.89-45.76%
2013-ยฃ66.1859.46%
2012-ยฃ41.5060.87%
2011-ยฃ25.80-68.49%
2010-ยฃ81.88-8.75%
2009-ยฃ89.73100%
2008-ยฃ44.87-71.43%
2007-ยฃ157.04-46.15%
2006-ยฃ291.6462.5%
2005-ยฃ179.47-52.94%
2004-ยฃ381.37-22.73%
2003-ยฃ493.54-24.14%
2002-ยฃ650.58-75.63%
2001-ยฃ2,670138%
2000-ยฃ1,122-39.76%
1999-ยฃ1,862-62.61%
1998-ยฃ4,980

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.00-471.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ0.57-142.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.42-205.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ0.71-47.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.52 12.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.47-135.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
-ยฃ2.57 91.11%๐Ÿ‡บ๐Ÿ‡ธ USA